Direxion Daily S&P Biotech Bear 3X Shares (LABD)
- Previous Close
7.62 - Open
7.83 - Bid 7.79 x 4000
- Ask 7.80 x 3100
- Day's Range
7.69 - 7.92 - 52 Week Range
5.72 - 29.92 - Volume
3,920,944 - Avg. Volume
14,231,598 - Net Assets 121.52M
- NAV 7.63
- PE Ratio (TTM) --
- Yield 5.19%
- YTD Daily Total Return -20.67%
- Beta (5Y Monthly) -2.64
- Expense Ratio (net) 1.10%
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
Direxion Funds
Fund Family
Trading--Inverse Equity
Fund Category
121.52M
Net Assets
2015-05-28
Inception Date
Performance Overview: LABD
Trailing returns as of 6/10/2024. Category is Trading--Inverse Equity.
People Also Watch
Holdings: LABD
Sector Weightings
Related ETF News
Research Reports: LABD
Newmont: Shares Remain Undervalued
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 6.9 million ounces of gold in 2024. However, after buying Newcrest, Newmont is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at end December 2023.
RatingPrice TargetLooking for more favorable entry point
Founded in 1921, Denver-based Newmont is the world's largest gold-mining company, with assets and operations in North America, South America, Australia/New Zealand, and Africa. While approximately 88% of its revenues come from gold, the company is also a major producer of copper. The company has about 21,700 employees. It is the only gold producer in the S&P 500.
RatingPrice TargetLowering target price to $38.00
AGNICO EAGLE MINES LTD has an Investment Rating of SELL; a target price of $38.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetNewmont: We Extend Coverage to Its Australian-Listed CDIs; Shares Undervalued
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 7.3 million ounces of gold in 2023 pro forma for Newcrest on an annualized basis. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts from its various gold mines. It had about two decades of gold reserves along with significant byproduct reserves after acquiring Newcrest.
RatingPrice Target